Abiopharma

🔍 Patel Yagnesh (Executive)

Company: Cerebras Systems Inc. (CBRS)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Sold 46 shares of Class A Common Stock at $189.36 per share (Direct)
  Date: 2026-06-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,954.00 | transaction_form_type: 4
• Sold 100 shares of Class A Common Stock at $161.61 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,854.00 | transaction_form_type: 4
• Sold 300 shares of Class A Common Stock at $163.29 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,554.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 100 shares of Class A Common Stock at $164.79 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,454.00 | transaction_form_type: 4
• Sold 200 shares of Class A Common Stock at $166.66 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,254.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 200 shares of Class A Common Stock at $168.45 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,054.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 300 shares of Class A Common Stock at $169.31 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,754.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 400 shares of Class A Common Stock at $171.99 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,354.00 | transaction_form_type: 4 | Footnotes: F5
• Sold 500 shares of Class A Common Stock at $173.36 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,854.00 | transaction_form_type: 4 | Footnotes: F6
• Sold 200 shares of Class A Common Stock at $175.01 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,654.00 | transaction_form_type: 4 | Footnotes: F7
• Sold 100 shares of Class A Common Stock at $176.12 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,554.00 | transaction_form_type: 4
• Sold 200 shares of Class A Common Stock at $178.36 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,354.00 | transaction_form_type: 4 | Footnotes: F8
• Sold 300 shares of Class A Common Stock at $179.56 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,054.00 | transaction_form_type: 4 | Footnotes: F9
• Sold 700 shares of Class A Common Stock at $180.83 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 354.00 | transaction_form_type: 4 | Footnotes: F10
• Sold 354 shares of Class A Common Stock at $182.05 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F11
• Acquired 15,000 shares of Class A Common Stock (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F12

Footnotes:

• F1: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $162.95 to $163.56, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F2: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $166.32 to $166.99, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F3: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $167.96 to $168.94, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F4: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $169.05 to $169.77, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F5: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $171.79 to $172.21, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F6: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $173.04 to $173.77, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F7: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $174.89 to $175.12, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F8: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $178.00 to $178.71, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F9: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $179.09 to $179.82, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F10: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $180.43 to $181.36, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F11: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $181.74 to $182.26, inclusive. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
• F12: Represents restricted stock units ("RSUs") that vest according to the terms of the applicable award agreement. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock.
• REMARKS: This Form 4 is the second of two Forms 4 being filed by the Reporting Person relating to transactions that occurred on June 25, 2026 and June 26, 2026 (the "Transaction Dates"). Because there are more than 30 rows associated with the Reporting Person's transactions that occurred on the Transaction Dates, and EDGAR will not allow for the entry of more than 30 rows on a single Form 4, this second Form 4 is being filed to report the transactions that were not included on the first Form 4. The two Forms 4 filed by the Reporting Person on the date hereof should be read together as one consolidated filing.